期刊文献+

哌啶基氯代苯甲酰胺非肽类小分子的合成及表征

Synthesis and Characterization of Piperidinyl Chloro-Benzamide Non-Peptide Small Molecule
原文传递
导出
摘要 在介导HIV进入细胞受体的过程中,非肽类小分子具有重要的药理学意义,开发具有高活性、高选择性及良好药代动力学性质的新药已成为研究的热点,该类小分子具有氯原子、苯甲酰胺、哌啶等活性基团而备受关注.本文合成了哌啶苯甲酰胺的邻对位二取代、对位以及邻位氯化物(7);通过(7)、1-(对氯苯甲氧基)-2-溴甲基-4-溴苯(3)合成了三种新的哌啶基氯代苯甲酰胺类非肽类小分子8a-8c,对三种氯代苯甲酰胺进行了生物活性检测及IR、MS、1H NMR表征.结果表明N-乙基-4-氯-N-(N-(2-对氯苯甲氧基-5-溴苯甲基)-4-哌啶基)苯甲酰胺8a具有较好的生物活性. Non- peptide small molecular has a great significance for pharmacology when mediated HIV goes into the cell receptor. It is necessary to develop novel drugs with high activity,high selectivity and good pharmacokinetic properties,which has become a hot spot. Among these small molecules,chlorine atomas group,benzamide and pyridine have attracted more research focus. In this paper,the intermediates( 7)( o,p- disubstituted,para and ortho benzamide piperidine chloride) are synthesized. Three benzamide chlorides are synthesized by the reaction of( 7)with 2-( bromomethyl)- 4- bromo- 1-(( 4- chlorobenzyl) oxy) benzene( 3). These chloride are then characterized by biological activity and IR,MS,1H NMR. The results show that the N- ethyl- 4- chloro- N-( 1-( 5- bromo- 2-(( 4- chlorophenmethyl) oxy) phenmethyl)- 4- piperidinyl) benzamide has a good biological activity.
出处 《昆明理工大学学报(自然科学版)》 CAS 2016年第1期97-101,共5页 Journal of Kunming University of Science and Technology(Natural Science)
基金 四川省教育厅基金项目(15ZB0215) 自贡市重点科技计划项目(2014ZC01)
关键词 哌啶 氯代 非肽类小分子 苯甲酰胺 piperidine chloride non-peptide small molecular benzamide
  • 相关文献

参考文献12

  • 1Mohammed A R,Nagul M S.Concise and simple synthesis of M1allosteric agonist TBPB[J].Synthetic Communications,2013,44(39):1796-1801.
  • 2焦诗卉,何淼.HIV辅助受体CCR5常见小分子抑制剂抑制效果的综合评价[J].中山大学学报(自然科学版),2012,51(6):97-102. 被引量:8
  • 3Ji Y J,Shu M,Wang Y Q,et al.Combined 3D-QSAR modeling and molecular docking study on azacycles CCR5 antagonists[J].Journal of Molecular Structure,2013,1045(6):35-41.
  • 4Skerlj R,Bridger G,Zhou Y X,et al.Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5antagonists that are potent inhibitors of M-tropic(R5)HIV-1 replication[J].Bioorganic and Medicinal Chemistry Letters,2011,21(23):6950-6954.
  • 5Ghvina G,Ringe R,Jayanta B.HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779[J].Med Sci entry for virus research,2011,158(1):216-224.
  • 6Song X M,Wang Z Y,Fu J H,et al.The Tandem Michael Addition-Elim Inationreaction of 5-Alkoxy-3,4-Dihalo-2(5h)-Furanone with Solvent DMF and Its reaction mechanism[J].Journal of South China Normal University:Natural Science Edition,2009(4):75-80.
  • 7Yuan L,Wu J Z,Chen G Q.Synthesis and characterization of 2,9-bis(2-imidazo{4,5-F}{1,10}phenanthroline)-1,10-phenanthroline[J].Journal of South China Normal University:Natural Science Edition,2002(4):104-108.
  • 8Lu S F,Chen B L,Dave D,et al.CCR5 receptor antagonists:Discovery and SAR of novel 4-hydroxypiperidine derivatives[J].Bioorganic and Medicinal Chemistry Letters,2007,17(7):1883-1887.
  • 9Finke P E,Oates B,Mills S G.Antagonists of the human CCR5 receptor as anti-HIV-1 agents.Part 4:synthesis and structure-activity relationships for 1-{N-(methyl)-N-(phenylsulfonyl)amino}-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes[J].Bioorganic and Medicinal Chemistry Letters,2001,11(18):2475-2479.
  • 10Ashwell M A,Lapierre J M,Kaplan A,et al.The design preparation and SAR of novel small molecule sodium(Na+)channel blockers[J].Bioorganic and Medicinal Chemistry Letters,2004,14(9):2025-2030.

二级参考文献11

  • 1韩燕星,蒋建东.CCR5:抗HIV-1药物的新靶点[J].中国医学科学院学报,2003,25(5):635-639. 被引量:8
  • 2刘瑶,苏靖,李松.CCR5小分子拮抗剂类抗艾滋病药物研究进展[J].国外医学(药学分册),2007,34(1):7-11. 被引量:2
  • 3DEL CORNO M,LIU QH,SCHOLS D. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent,pertussis toxin-insensitive chemokine receptor signaling[J].Blood,2001,(10):2909-2916.
  • 4CECILE L.T,FRANCOISE G,C,HRISTOPHER K. Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125),a CCR5 antagonist with other antiretroviral agents in vitro[J].Antimicrobial Agents and Chemotherapy,2002,(05):1336-1339.doi:10.1128/AAC.46.5.1336-1339.2002.
  • 5YOGANATHAN K,ROSSANT C,NG S. 10-Methoxydihydrofuscin,fuscinarin,and fuscin,novel antagonists of the human CCR5 receptor from Oidiodendron griseum[J].Journal of Natural Products,2003,(08):1116-1117.
  • 6PALANI A,SHAPIRO S,CLADER J W. Discovery of 4-[(z)-(4-bromophenyl)-(ethoxyimino)methyl]-1(′)[(2,4-dimethyl-3-pydinyl)carbonyl]-4(")-methyl-1,4(′)-bipiperidine N-oxide(SCH351125):an orally bioavailable human CCR5 antagonist for the treatment of HIV infection[J].Journal of Medicinal Chemistry,2001,(21):3339-3342.doi:10.1021/jm015526o.
  • 7STRIZKI JM,TREMBLAY C,XU S. Discovery and charaeterization of vicriviroc(SCH 417690),a CCR5 antagonist with potent activity against human immunodeficiency virus type 1[J].Antimicrobial Agents and Chemotherapy,2005,(12):4911-4919.doi:10.1128/AAC.49.12.4911-4919.2005.
  • 8WOOD A,AMLOUR D. The discovery of the CCR5 receptor antagonist,UK-427,857,a new agent for the treatment of HIV infection and AIDS[J].Progress in Medicinal Chemistry,2005.239-271.
  • 9LYNCH C L,GENTRY A L,HALE J J. CCR5 antagonists:bicyclic isoxazolidines as conformationally constrained N-(l)-substituted pyrolidines[J].Bioorganic and Medicinal Chemistry Letters,2002,(04):677-679.doi:10.1016/S0960-894X(01)00835-6.
  • 10JAYASURIYA H,HERATH K B,ONDEYKA J G. Isolation and structure of antagonists of chemokine receptor(CCR5)[J].Journal of Natural Products,2004,(06):1036-1038.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部